Seoul opens the Future of Biomedical Industry
Seoul metropolitan government invest intensively in the biomedical industry.
No.1 City Seoul Clinical trial market share for 5 consecutive years
The government operates 17 clinical trial centers across the country.
Standardization of clinical trials addresses safety and ethical issues.
Seoul with the Best Environment for the Biomedical Industry
- Biomedical cluster Hongneung, Seoul
- BT+IT, Seoul with active convergence of technologies
- Korean venture capital (VC), 1st place in investment by industry Biomedical Sector
- Medical big data of 50 million people nationwide
Biomedical Companies Leading Innovation
-
LG Chem
Brand Value Global TOP3
Top-notch pipeline in Korea
-
Standigm
Biomedical startup in Seoul TOP 3 in the cumulative investment attraction
-
HUINNO
1st place in Global Artificial Intelligence (AI) Competition
-
geninus
CancerSCAN with a Korean market share of over 50%
Practicing ESG Management in the Biomedical Industry
-
Macrogen
Established ESG Committee for the first time in the industry
Contributed to the Ministry of National Defense's remains excavation project with the excellent genome analysis technology
-
Boryung
Implemented upcycling of waste medicine containers for the first time in the industry
Support for the protection of natural and cultural landscapes in national parks
Seoul's Efforts for Biomedical Industry
-
Creation of Hongneung Biomedical Cluster
Hongneung R&D Anchor Seoul Bio Hub
Hongneung BT-IT Convergence Center
-
Seoul with Excellent Partners
- seoul samsung hospital
- seoul asan medical center
- KIST
Korea's major university hospitals and general hospitals are concentrated in Seoul.
MOU with 13 universities and research institutes in Hongneung
-
Open Innovation with Global Big Pharma
NOVARTIS
Seoul Innovation QuickFire Challenge
Health X-Challenge Seoul